A high incidence of both autoantibodies' 2 and rheumatoid factor3 is a well recognised feature of systemic sclerosis. Interest in the possibility of an immunological pathogenesis for the disorder, however, has come principally from the observations of Trayanova et al.4 and Currie et al.5 that lymphocytes from patients with the disorder showed elevated levels of cytotoxicity towards cultured target cells. Additional impetus for this concept was provided by the recognition that graft-versus-host disease, initially in experimental animals6 and later in man,78 might be complicated by sclerodermatous lesions. However, an element of controversy has been introduced into the literature by rather Cytotoxicity assays. Target cells were labelled with 51Cr as previously described"1 and incubated in Eagle's basal medium with 10 % fetal bovine serum at a concentration at 2 x 104 cells with either 5 x 105 peripheral blood mononuclear cells or 200 ,ul whole blood. Triplicate cultures were maintained for 18 hours at 37°C and the 'percentage specific cytotoxicity' was then calculated from the 51Cr release, as previously described.1 414
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Statistical methods. Comparison of the cytotoxicity data in patients and control groups was made by the Mann-Whitney ranking test.
Results
The results of the cytotoxicity assays against the 4 established cell lines using both whole blood and peripheral blood mononuclear cells from patients with systemic sclerosis and controls are summarised in Table 1 . Although levels of cytotoxicity were generally higher in whole blood assays, neither effector system revealed any difference between the patient and control groups. Although the data are not presented, analysis of the patients with systemic sclerosis in terms of 'severe' and 'mild' disease also failed to reveal any significant difference in levels of cytotoxicity from that found in controls. 
